APA

Wire M. B., Fang L., Hussaini A., Kleha J. F. & Theodore D. (20150803). Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir. : Antimicrobial agents and chemotherapy.

Chicago

Wire Mary Beth, Fang Lei, Hussaini Azra, Kleha Joseph F and Theodore Dickens. 20150803. Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir. : Antimicrobial agents and chemotherapy.

Harvard

Wire M. B., Fang L., Hussaini A., Kleha J. F. and Theodore D. (20150803). Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir. : Antimicrobial agents and chemotherapy.

MLA

Wire Mary Beth, Fang Lei, Hussaini Azra, Kleha Joseph F and Theodore Dickens. Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir. : Antimicrobial agents and chemotherapy. 20150803.